32222-47-2

Basic information

• Product Name: (2R)-2-(3-fluorophenyl)-2-hydroxyacetic acid
• CAS NO: 32222-47-2
• Molecular Weight: 170.14
• Mol File: 32222-47-2.mol
• Article Data: 21

Chemical Properties

• CAS DataBase Reference: (2R)-2-(3-fluorophenyl)-2-hydroxyacetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (2R)-2-(3-fluorophenyl)-2-hydroxyacetic acid(32222-47-2)
• EPA Substance Registry System: (2R)-2-(3-fluorophenyl)-2-hydroxyacetic acid(32222-47-2)

Safety Data

• Hazardous Substances Data: 32222-47-2(Hazardous Substances Data)

Upstream product

• 1384954-21-5 2-acetoxy-2-(3-fluorophenyl)acetic acid 
• 455-36-7 1-(3-fluorophenyl)ethanone 
• 79477-87-5 2-(3-fluorophenyl)-2-oxoacetic acid 
• 456-48-4 3-Fluorobenzaldehyde 
• 143103-67-7 2-(3-fluorophenyl)-2-hydroxyacetonitrile 
• 1170715-55-5 C₈H₆FNO 
• 773837-37-9 sodium cyanide 
• 75-77-4 chloro-trimethyl-silane 
• 151-50-8 potassium cyanide 
• 100948-28-5 2-(3-fluorophenyl)-2-((trimethylsilyl)oxy)acetonitrile 
• 52944-27-1 (R,S)-2-hydroxy-2-(3-aminophenyl)acetic acid 
• 32222-47-2 2-(3-fluorophenyl)-2-hydroxyacetic acid 

Downstream Products

• 395-05-1 (2R)-2-(3-fluorophenyl)-2-hydroxyacetic acid 
• 395-05-1 (S)-2-(3-fluorophenyl)-2-hydroxyacetic acid 
• 79477-87-5 2-(3-fluorophenyl)-2-oxoacetic acid 
• 1384954-21-5 2-acetoxy-2-(3-fluorophenyl)acetic acid 
• 1072449-67-2 C₈H₆ClFO₂ 
• 17199-29-0 (S)-Mandelic acid 
• 611-71-2 (R)-Mandelic Acid 
• 25698-44-6 (R)-3-fluorophenylglycine 
• 455-37-8 3-fluorobenzamide 

Relevant articles and documents

PERK INHIBITING PYRROLOPYRIMIDINE COMPOUNDS

Provided herein are compounds of formula (I), compositions, and methods useful for inhibiting PERK and for treating related conditions diseases, and disorders.

PERK INHIBITING INDOLINYL COMPOUNDS

Provided herein are compounds of formula (I), compositions, and methods useful for inhibiting PERK and for treating related conditions diseases, and disorders, wherein Q is selected from (Ia), (Ib) ou (Ic).

PERK INHIBITORS FOR TREATING VIRAL INFECTIONS

Provided herein are methods for treating a viral infection in a patient, comprising administering to said patient a therapeutically effective amount of a PERK inhibitor selected from a compound having the structure (I):